| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |